Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Health outcomes during the first wave of COVID-19 in Catalonia, Spain, have been described in detail in a study published by Nature Communications.

Coronavirus modelling

These findings provide new insights into the early months of the pandemic and will help to inform the ongoing response, such as vaccination strategies.

Using data from over 5.5 million individuals, representing around 80% of the population of Catalonia, the study identified 102,002 patients who had an outpatient diagnosis of COVID-19, 16,901 who were hospitalised with COVID-19, and 5,273 who died after either being diagnosed or hospitalised with COVID-19 between 1st March and 6th May 2020.

On examining the characteristics of those with COVID-19, older age was the factor most strongly associated with worse outcomes (hospitalisations and deaths). Of the COVID-19 deaths observed, more than 80% were among individuals aged 70 or older. While COVID-19 deaths were concentrated among those at oldest ages, hospitalisations were less so. In fact, close to 40% of those hospitalised after an outpatient diagnosis of COVID-19 were aged between 40 and 59. Males were also seen to be at an increased risk of worse outcomes, making up 60% of deaths. Comorbidities were also associated with worse outcomes, although after adjusting for age and sex their impact were generally most pronounced among younger patients.

Read the full story on the Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences website.

Similar stories

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

Medical Sciences Division receives REF 2021 results

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021. REF is the UK-wide assessment of research in universities, and provides an expert evaluation of the quality of the research outputs, impact and environment at subject level in each university.